Indefinite Delivery Contract 75N95023D00006
Award Date
1/31/23
Last Date to Order
1/30/30
Funding Federal Agency
National Institute of Mental Health
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health's National Institute on Drug Abuse (NIDA) awarded a $149 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the New York Genome Center, Inc. (doing business as Nygc) to provide sequencing services for the BRAIN Initiative Cell Atlas Network (BICAN). Under this master IDIQ, NIDA has issued two task orders to Nygc totaling over $110 million for brain cell sequencing work. The first $73.8 million task order is for unspecified BICAN sequencing...
This is a multiple award Indefinite Delivery Contract (IDC) awarded by the National Institute of Mental Health, a component of the National Institutes of Health, to provide DNA sequencing services in support of the BRAIN Initiative Cell Atlas Network (BICAN) program. The $149 million contract has a performance period through January 2030. The University of Washington, a large public research university, is one of the prime contractors under this IDC. The university holds a $500 million...
This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to The Broad Institute, Inc., a non-profit biomedical and genomic research organization. The $49.8 million IDC supports the NCI Genomic Characterization Centers and provides comprehensive genomic sequencing, data analysis, and other advanced computational biology services to NCI institutes and centers. Under the IDC, The Broad Institute has been awarded multiple task...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services awarded a single award indefinite delivery contract with a potential value of $500 million to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract aims to support the Trans-Omics for Precision Medicine initiative through the provision of genomics data generation, analysis, and management services. Under the contract, the National...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS) has awarded a $750,000 indefinite delivery contract to 10X Genomics, Inc. for the delivery of 10X Genomics optimization slides, reagent kits, and reagent delivery methods. The single-award IDC aims to provide NINDS with 10X Genomics' single-cell analysis tools and services to support the institute's biomedical research into neurological diseases and disorders. Under this contract, NINDS has issued...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, an Indefinite Delivery Contract (IDC) valued at $149.2 million. The purpose of this contract is to provide manufacturing and nonclinical studies support for the development of therapeutic biotechnology products for neurological-related disorders. Under this IDC, NINDS...
The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded an indefinite delivery contract (IDC) valued at up to $7,000,000 to 10X Genomics, Inc. to provide optimization slides, reagent kits, and reagent delivery methods to support research efforts into neurological diseases and disorders. As the prime contractor, 10X Genomics, a life sciences technology company, has delivered a range of specialized genomic analysis platforms,...
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity multiple award contract to Battelle Memorial Institute for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders. The original solicitation sought to procure manufacturing and nonclinical services over five years to support the development of biotechnology products for...
This indefinite delivery contract (IDC) was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to The Johns Hopkins University, a private non-profit research institution. The $98.88 million single-award IDC has an ultimate completion date of May 31, 2031 and provides high-throughput genotyping and DNA sequencing services to study the genetic contributions to human health and disease. The contract has...
Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH). The IDC has a ceiling value of $92,416,478 and a period of performance through March 2, 2026. Under this IDC and associated delivery orders, Illumina will provide a range of its advanced sequencing instruments,...